Cadherins and Epithelial-to-Mesenchymal Transition

被引:273
|
作者
Gheldof, Alexander [1 ,2 ]
Berx, Geert [1 ,2 ]
机构
[1] VIB, Dept Mol Biomed Res, Unit Mol & Cellular Oncol, Ghent, Belgium
[2] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium
来源
关键词
TRANSCRIPTION FACTOR ZEB1; N-CADHERIN; CELL-ADHESION; BETA-CATENIN; EXPRESSION PATTERN; ESTROGEN-RECEPTOR; TUMOR PROGRESSION; UP-REGULATION; BHLH FACTORS; F-ACTIN;
D O I
10.1016/B978-0-12-394311-8.00014-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epithelial mesenchymal transition (EMT) is a process whereby epithelial cells are transcriptionally reprogrammed, resulting in decreased adhesion and enhanced migration or invasion. EMT occurs during different stages of embryonic development, including gastrulation and neural crest cell delamination, and is induced by a panel of specific transcription factors. These factors comprise, among others, members of the Snail, ZEB, and Twist families, and are all known to modulate cadherin expression and, in particular, E-cadherin. By regulating expression of the cadherin family of proteins, EMT-inducing transcription factors dynamically modulate cell adhesion, allowing many developmental processes to take place. However, during cancer progression EMT can be utilized by cancer cells to contribute to malignancy. This is also reflected at the level of the cadherins, where the cadherin switch between E- and N-cadherins is a classical example seen in cancer-related EMT. In this chapter, we give a detailed overview of the entanglement between EMT-inducing transcription factors and cadherin modulation during embryonic development and cancer progression. We describe how classical cadherins such as E- and N-cadherins are regulated during EMT, as well as cadherin 7, -6B, and -11.
引用
收藏
页码:317 / 336
页数:20
相关论文
共 50 条
  • [1] The Epithelial-to-Mesenchymal Transition in Cancer
    Roche, Joelle
    CANCERS, 2018, 10 (02):
  • [2] The Role of Epithelial-to-Mesenchymal Transition in Cutaneous Squamous Cell Carcinoma Epithelial-to-Mesenchymal Transition in Cutaneous SCC
    Fernandez-Figueras, Maria-Teresa
    Puig, Luis
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (06)
  • [3] Epithelial-to-Mesenchymal Transition in Pancreatic Adenocarcinoma
    Cano, Carla
    Motoo, Yoshiharu
    Iovanna, Juan L.
    THESCIENTIFICWORLDJOURNAL, 2010, 10 : 1947 - 1957
  • [4] EPITHELIAL-TO-MESENCHYMAL TRANSITION AND LUNG FIBROSIS
    Tam, A.
    Sonnylal, S.
    Leask, A.
    Denton, C. P.
    de Crombrugghe, B.
    Norman, J.
    Abraham, D. J.
    RHEUMATOLOGY, 2012, 51 : 123 - 123
  • [5] Peritoneal dialysis and epithelial-to-mesenchymal transition
    Stein, JA
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (20): : 2037 - 2037
  • [6] Growth Hormone and the Epithelial-to-Mesenchymal Transition
    Brittain, Alison L.
    Basu, Reetobrata
    Qian, Yanrong
    Kopchick, John J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (10): : 3662 - 3673
  • [7] Polyamines modulate epithelial-to-mesenchymal transition
    Alessandra, Compagnone
    Andrea, Bandino
    Floriana, Meli
    Vittoria, Bravoco
    Carlo, Cravanzola
    Maurizio, Parola
    Sebastiano, C.
    AMINO ACIDS, 2012, 42 (2-3) : 783 - 789
  • [8] Epithelial-to-mesenchymal transition induced by virus
    Hincapie, Victoria
    Carlos Gallego-Gomez, Juan
    ACTA BIOLOGICA COLOMBIANA, 2021, 26 (01): : 105 - 115
  • [9] Arginine methylation in the epithelial-to-mesenchymal transition
    Qin, Jian
    Xu, Jian
    FEBS JOURNAL, 2022, 289 (23) : 7292 - 7303
  • [10] Epithelial-to-mesenchymal transition in tumor progression
    Prieto-Garcia, Elena
    Vanesa Diaz-Garcia, C.
    Garcia-Ruiz, Inmaculada
    Teresa Agullo-Ortuno, M.
    MEDICAL ONCOLOGY, 2017, 34 (07)